500-Patient trial tracks brain aneurysm device over 5 years
Disease control
Ongoing
This study follows 500 people who received the Surpass Evolve flow diverter to treat brain aneurysms. Researchers will track safety and how well the device works over 5 years, including rates of stroke, death, and complete aneurysm closure. The goal is to confirm the device's lon…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated May 22, 2026 13:53 UTC